Opinion statement
Early gastric cancer (EGC), defined as being confined to the submucosa, is a curable condition. In recent years, endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) have been widely applied to subgroups of mucosal cancers, thereby avoiding the burden of operation while preserving gastric function. However, it can be difficult to identify mucosal cancers, which often evade detection due to their flat shapes without ulceration. Proper preparation to clean the mucosal surface, detailed systematic observation of the entire stomach, and the use of high-resolution systems for both endoscopies equipped with image-enhanced modality and monitors would facilitate the detection of such lesions. It is also critical to evaluate the resected specimen to confirm completeness of resection (tumor-free lateral and vertical margins as well as the absence of lymphatic and vascular invasion). If the resection is incomplete, further treatment is usually recommended—further endoscopic resection for patients with positive lateral margins or surgery for patients with positive vertical margins or with lymphatic or vascular involvement. The five-year survival for endoscopically resected EGC is excellent—and comparable to that of surgical therapy. Since most gastric cancers are caused by Helicobacter pylori, this infection should be tested for routinely. If a patient is H. pylori-positive, eradication is recommended, as heterotopic, metachronous recurrence of EGC is subsequently reduced. Importantly, basic principles for early diagnosis and endoscopic treatment of EGC can be applied to neoplasms arising in other parts of the gut, such as the esophagus and colon, and would be beneficial for patients through preserving organ function and minimizing operative intervention.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published in recent years, have been highlighted as: • Of importance •• Of major importance
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.
Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg. 1992;79:245–7.
Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer. 1996;77:602–6.
Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.
Tada M, Shimada M, Murakami F, Mizumachi M, Arima K, Yanai H, et al. Development of strip-off biopsy. Gastroenterol Endosc. 1984;26:833–9. in Japanese with English abstract.
Hirao H, Takeshita K, Hori H, Muraoka Y, Yoneshima H. Endoscopic resection of early gastric cancer and other tumors with local injection of hypertonic saline-epinephrine. Gastrointest Endosc. 1988;34:264–9.
Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc. 1993;39:58–62.
Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–9.
Yamamoto H, Sekine Y, Higashizawa T, Kihira K, Kaneko Y, Hosoya Y, et al. Successful en bloc resection of a large superficial gastric cancer by using sodium hyaluronate and electrocautery incision forceps. Gastrointest Endosc. 2001;54:629–32.
Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S. New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy. 2001;33:221–6.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver.3). Gastric Cancer. 2011;14:113–23. This guideline described the principles of therapy for gastric cancer including endoscopic treatment. In Japan, version 4 was published which will be translated into English. Guidelines for endoscopic resection are similar in version 4.
Schlemper RJ, Itabashi M, Kato Y, Lewin KJ, Riddell RH, Shimoda T, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet. 1997;349:1725–29.
Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol. 2001;36:445–56.
Rugge M, Cassaro M, Pennelli G, Russo VM, Di Mario F, Farinati F. Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions. Gut. 2003;52:453–4.
Rugge M, Cassaro M, Di Mario F, Leo G, Leandro G, Russo VM, et al. The long term outcome of gastric non-invasive neoplasia. Gut. 2003;52:1111–16.
Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawser SM et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000; 47: 251–5.
Schlemper RJ, Kato Y, Stolte M. Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol. 2000;15:G49–57.
Tanaka K, Toyoda H, Kadowaki S, Hamada Y, Kosaka R, Matusaki S, et al. Surface pattern classification by enhanced-magnification endoscopy for identifying early gastric cancer. Gastrointest Endosc. 2008;67:430–7.
Kaise M, Kato M, Urashima M, Kaneyama H, Kanazawa Y, Yonezawa J, et al. Magnifying endoscopy combined with narrow-band imaging for differential diagnosis of superficial depressed gastric lesions. Endoscopy. 2009;41:310–5.
Pimentel-Nunes P, Dinis-Ribeiro M, Soares JB, Marcos-Pinto R, Santos C, Rolanda C, et al. A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions. Endoscopy. 2012;44:236–46.
Yao K. How is the VS (vessel plus surface) classification system applicable to magnifying narrow-band imaging examinations of gastric neoplasia initially diagnosed as low-grade adenomas? Gastric Cancer. 2012;15:118–20. This article described the classification of the microsurface pattern and microvessel patterns which has been accepted as a useful in the differential diagnosis of cancerous vs. noncancerous mucosa.
Osawa H, Yoshizawa M, Yamamoto H, Kita H, Satoh K, Ohnishi H, et al. Optimal band imaging system can facilitate detection of changes in depressed-type early gastric cancer. Gastrointest Endosc. 2008;67:226–34.
Yoshizawa M, Osawa H, Yamamoto H, Kita H, Nakano H, Satoh K, et al. Diagnosis of elevated-type early gastric cancers by the optimal band imaging system. Gastrointest Endosc. 2009;69:19–28.
Kaneko K, Oono Y, Yano T, Ikematsu H, Odagaki T, Odagaki T, et al. Effect of novel bright image enhanced endoscopy using blue laser imaging (BLI). Endoscopy Int Open. 2014;02:E212–9.
Osawa H, Yamamoto H, Miura Y, Sasao W, Ino Y, et al. Blue laser imaging provides excellent endoscopic images of upper gastrointestinal lesions. Video J Encycl GI Endoscopy. 2014. doi:10.1016/j.vjgien.2014.01.001.
Yagi K, Nakamura A, Sekine A. Comparison between magnified endoscopy and histological, culture and urease test findings from the gastric mucosa of the corpus. Endoscopy. 2002;24:376–81.
Anagnostopoulos GK, Yao K, Kayer P, et al. High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy. Endoscopy. 2007;39:202–7.
Uedo N, Ishihara R, Ishii H, et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy. 2006;38:819–24.
Sugano K, Sato K, Yao K. New diagnostic approaches for early detection of gastric cancer. Dig Dis. 2004;22:327–33.
Veitch AM, Uedo N, Yao K, East JE. Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Rev Gastroenterol Hepatol. 2015. doi:10.1038/nrgastro.2015.128. This paper published very recently was written from the viewpoint of Western gastroenterologists. However, there are a number of useful points that can be applied to daily clinical practice. Many points raised in this article are consistent with the view of this review article.
Ezoe Y, Muto M, Horimatsu T, Minashi K, Yano T, Sano Y, et al. Magnifying narrow-band imaging versus magnifying white-light imaging for the differential diagnosis of gastric small depressive lesions: a prospective study. Gastrointest Endosc. 2010;71:477–84.
Kato M, Kaise M, Yonezawa J, Toyoizumi H, Yoshimura N, Yoshida Y, et al. Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc. 2010;72:523–9.
Ezoe Y, Muto M, Uedo N, Doyama H, Yao K, Oda I, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141:2017–25.
Yagi K, Aruga Y, Nakamura A, Sekine A, Umezu H. The study of dynamic chemical magnifying endoscopy in gastric neoplasia. Gastrointest Endosc. 2005;62:963–9.
Sakai Y, Eto R, Kasanuki J, Kondo F, Kato K, Arai M, et al. Gastrointest Endosc. 2008;68:635–41.
Yanai H, Noguchi T, Mizumachi S, Tokiyama H, Nakamura H, Tada M, et al. A blind comparison of the effectiveness of endoscopic ultrasonography and endoscopy in staging early gastric cancer. Gut. 1999;44:361–5.
Yoshida T, Kawachi H, Sasajima K, Shiokawa A, Kudo S. The clinical meaning of a nonstructural pattern in early gastric cancer on magnifying endoscopy. Gastrointest Endosc. 2005;62:48–54.
Kobara H, Mori H, Fujihara H, Kobayashi M, Nishiyama N, Nomura T, et al. Prediction of invasion depth for submucosal differentiated gastric cancer by magnifying endoscopy with narrow-band imaging. Oncol Rep. 2012;28:841–7.
Kaneko T, Sekikawa A, Tsumura T, Maruo T, Osaki Y, Wakasa T, et al. Absent microsurface pattern is characteristic of early gastric cancer of undifferentiated type: magnifying endoscopy with narrow-band imaging. Gastrointest Endosc. 2014;88:1194–8.
Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.
Sawada S, Fujisaki J, Yamamoto N, Kato Y, Ishiyama A, Ueki N, et al. Expansion of indications for endoscopic treatment of undifferentiated mucosal gastric cancer: analysis of intramucosal spread in resected specimen. Dig Dis Sci. 2010;55:1376–80.
Gotoda T, Yamamoto H, Soetikno R. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol. 2006;41:929–42.
Haruta H, Hosoya Y, Sakuma K, Shibusawa H, Satoh K, Yamamoto H, et al. Clinicopathological study of lymph-node metastasis in 1,389 patients with early gastric cancer: assessment of indications for endoscopic resection. J Dig Dis. 2008;9:213–8.
Jee YS, Hwang SH, Rao J, Park DJ, Kim HH, Lee HJ, et al. Safety of extended endoscopic mucosal resection and endoscopic submucosal dissection following the Japanese Gastric Cancer Association treatment guidelines. Br J Surg. 2009;96:1157–61.
Lee HL, Eun CS, Lee OY, Han DS, Yoon BC, Choi HS, et al. When do we miss synchronous gastric neoplasms with endoscopy? Gastrointest Endosc. 2010;71:1159–65.
Kopelman Y, Siersema PD, Bapaye A, Kopelman D. Endoscopic full-thickness GI wall resection: current status. 2012; 75: 165-73
Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy. 2009;41:751–7.
Lian J, Chen S, Zhang Y, Qiu F. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc. 2012;76:763–70.
Yamamoto H, Yahagi N, Oyama T, Gotoda T, Doi T, Hirasaki S, et al. Usefulness and safety of 0.4 % sodium hyaluronate solution as a submucosal fluid “cushion” in endoscopic resection for gastric neoplasms: a prospective multicenter trial. Gastrointest Endosc. 2008;67:830–9.
Yang Z, Wu Q, Liu Z, Wu K, Fan D. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection of endoscopic submucosal dissection: a meta-analysis of randomized trials. Digestion. 2011; 315-20
Yoon SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter. 2014;19:243–8. This meta-analysis provides evidence that H. pylori should be eradicated after endoscopic resection, if the patients are positive for the infection. Previous reviews on endoscopic therapy for early gastric cancer often ignored this important practice to reduce the metachronous development of gastric cancer.
Oda I, Gotoda T, Sasako M, Sano T, Katai H, fukagawa T, et al. Treatment strategy after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2008; 1495-1500.
Sekiguchi M, Suzuki H, Oda I, Abe S, Nonaka S, Yoshinaga S, et al. Favorable long-term outcomes of endoscopic submucosal dissection for locally recurrent early gastric cancer after endoscopic resection. Endoscopy. 2013;45:708–13.
Goto O, Fujishiro M, Kodashima S, Ono S, Omata M. Outcomes of endoscopic submucosal dissection for early gastric cancer with special reference to validation for curability criteria. Endoscopy. 2009;41:118–22.
Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009;58:331–6.
Ahn JY, Jung HW, Choi KE, Choi JY, Kim MY, Lee JH, et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc. 2011;74:485–93.
Kurokawa Y, Hasuike N, Ono H, Boku N, Fukuda H, for the Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group (JCOG). A phase II trial of endoscopic submucosal dissection for mucosal gastric cancer: Japan Clinical Oncology Group Study JCOG0607. Jpn J Clin Oncol. 2009;39:464–6.
Kim JJ, Lee JH, Jung HY, Lee GH, Cho JY, Ryu CB, et al. EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc. 2007;66:693–700.
Chung IK, Lee JH, Lee SH, Kim SJ, Cho JY, Cho WY, et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc. 2009;69:1228–35.
Deprez PH, Bergman JJ, Meisner S, Ponchon T, Repici A, Dinis-Ribeiro M, et al. Current practice with endoscopic submucosal dissection in Europe: position statement from a panel of experts. Endoscopy. 2010;42:853–8.
Lau M, Le A, El-Serag HB. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006;101:2485–92.
Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015.
International Agency for Research on Cancer. Helicobacter pylori eradication as a strategy for preventing gastric cancer. IARC working group report 8. 2014. Lyon. In this report, the IARC has announced that H. pylori eradication can prevent gastric cancer and hence the infection should be eradicated as a primary preventive measure when feasible.
Ford ACF, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomized controlled trial. BMJ 348;g3174 doi: 10.1136/bmj.g3174.
Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–67. The first comprehensive consensus report on H. pylori gastritis covering classification of gastritis, differentiation of functional dyspepsia and H. pylori gastritis, diagnosis and grading of gastritis, and therapeutic strategy of H. pylori gastritis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Kentaro Sugano has received lecture fees from Fujifilm Medical Inc.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Stomach
Rights and permissions
About this article
Cite this article
Sugano, K. Detection and Management of Early Gastric Cancer. Curr Treat Options Gastro 13, 398–408 (2015). https://doi.org/10.1007/s11938-015-0070-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11938-015-0070-y